TheEdgeResearch
Home / Stocks / EMBC

Embecta Corp. (EMBC)

NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
$3.11 ▲ +0.65%
Market Cap
$184.5M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.81
52-Wk Range
2.77-15.55
CEO
Devdatt Kurdikar
Country
US
Currency
USD

Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 19…

Open full interactive analysis & DCF →